Cargando…
CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors
C-terminal Binding Proteins (CtBP) 1 and 2 are oncogenic transcriptional co-regulators overexpressed in many cancer types, with their expression level correlating to worse prognostic outcomes and aggressive tumor features. CtBP negatively regulates the expression of many tumor suppressor genes, whil...
Autores principales: | Dcona, M. Michael, Morris, Benjamin L., Ellis, Keith C., Grossman, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536941/ https://www.ncbi.nlm.nih.gov/pubmed/28532298 http://dx.doi.org/10.1080/15384047.2017.1323586 |
Ejemplares similares
-
Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins
por: Bergman, Lee M, et al.
Publicado: (2006) -
DNA methylation is involved in the pathogenesis of osteoarthritis by regulating CtBP expression and CtBP-mediated signaling
por: Sun, Xiangxiang, et al.
Publicado: (2020) -
An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition
por: Chawla, Ayesha T., et al.
Publicado: (2018) -
CtBP2 proteome: Role of CtBP in E2F7-mediated repression and cell proliferation
por: Zhao, Ling-Jun, et al.
Publicado: (2014) -
CtBP—a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma
por: Chawla, Ayesha T., et al.
Publicado: (2019)